Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML)
Outcome of discontinuation of imatinib therapy after achieving a molecular remission
To access this article, please choose from the options below
PII: S0145-2126(05)00053-6
doi:10.1016/j.leukres.2005.01.009
© 2005 Elsevier Ltd. All rights reserved.
